NeuroMetrix Net Income vs Cost of Revenue Analysis

NURO Stock  USD 4.16  0.16  4.00%   
NeuroMetrix financial indicator trend analysis is infinitely more than just investigating NeuroMetrix recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether NeuroMetrix is a good investment. Please check the relationship between NeuroMetrix Net Income and its Cost Of Revenue accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuroMetrix. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.

Net Income vs Cost Of Revenue

Net Income vs Cost of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of NeuroMetrix Net Income account and Cost of Revenue. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between NeuroMetrix's Net Income and Cost of Revenue is -0.21. Overlapping area represents the amount of variation of Net Income that can explain the historical movement of Cost of Revenue in the same time period over historical financial statements of NeuroMetrix, assuming nothing else is changed. The correlation between historical values of NeuroMetrix's Net Income and Cost of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income of NeuroMetrix are associated (or correlated) with its Cost of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost of Revenue has no effect on the direction of Net Income i.e., NeuroMetrix's Net Income and Cost of Revenue go up and down completely randomly.

Correlation Coefficient

-0.21
Relationship DirectionNegative 
Relationship StrengthInsignificant

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in NeuroMetrix financial statement analysis. It represents the amount of money remaining after all of NeuroMetrix operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Cost Of Revenue

Cost of Revenue is found on NeuroMetrix income statement and represents the costs associated with goods and services NeuroMetrix provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.
Most indicators from NeuroMetrix's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NeuroMetrix current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuroMetrix. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.As of the 28th of March 2024, Selling General Administrative is likely to drop to about 4.7 M. In addition to that, Issuance Of Capital Stock is likely to drop to about 2.5 M
 2021 2022 2023 2024 (projected)
Gross Profit5.9M5.8M3.9M3.8M
Total Revenue8.3M8.3M5.9M5.6M

NeuroMetrix fundamental ratios Correlations

0.67-0.2-0.51-0.320.46-0.240.21-0.35-0.19-0.43-0.220.21-0.08-0.210.250.67-0.31-0.08-0.190.110.090.44-0.230.57-0.17
0.67-0.32-0.43-0.420.7-0.15-0.08-0.35-0.37-0.45-0.170.38-0.34-0.30.120.98-0.240.08-0.320.15-0.160.53-0.380.69-0.3
-0.2-0.320.550.630.090.340.180.380.02-0.330.66-0.02-0.25-0.38-0.61-0.320.150.46-0.350.050.670.28-0.28-0.14-0.39
-0.51-0.430.550.870.070.060.080.60.14-0.260.7-0.15-0.31-0.38-0.67-0.510.550.3-0.420.450.610.23-0.32-0.33-0.42
-0.32-0.420.630.87-0.02-0.040.090.810.02-0.160.89-0.03-0.17-0.24-0.58-0.490.670.25-0.30.560.790.12-0.19-0.3-0.3
0.460.70.090.07-0.02-0.110.13-0.25-0.32-0.810.110.33-0.76-0.88-0.540.71-0.310.29-0.90.190.180.89-0.930.48-0.88
-0.24-0.150.340.06-0.04-0.11-0.35-0.06-0.160.2-0.040.15-0.27-0.09-0.25-0.06-0.150.520.07-0.4-0.12-0.180.07-0.31-0.05
0.21-0.080.180.080.090.13-0.35-0.380.14-0.410.11-0.10.37-0.19-0.04-0.09-0.32-0.36-0.220.020.020.35-0.210.52-0.2
-0.35-0.350.380.60.81-0.25-0.06-0.380.040.150.73-0.06-0.110.1-0.27-0.430.810.320.040.60.66-0.180.14-0.460.06
-0.19-0.370.020.140.02-0.32-0.160.140.04-0.05-0.11-1.00.240.190.17-0.460.21-0.10.20.310.05-0.040.2-0.260.21
-0.43-0.45-0.33-0.26-0.16-0.810.2-0.410.15-0.05-0.160.030.560.820.45-0.40.27-0.310.81-0.33-0.39-0.990.82-0.490.8
-0.22-0.170.660.70.890.11-0.040.110.73-0.11-0.160.1-0.15-0.24-0.56-0.240.650.31-0.320.550.720.15-0.22-0.11-0.32
0.210.38-0.02-0.15-0.030.330.15-0.1-0.06-1.00.030.1-0.23-0.2-0.160.46-0.240.08-0.21-0.32-0.050.06-0.220.29-0.22
-0.08-0.34-0.25-0.31-0.17-0.76-0.270.37-0.110.240.56-0.15-0.230.840.73-0.370.1-0.60.8-0.13-0.32-0.640.80.080.82
-0.21-0.3-0.38-0.38-0.24-0.88-0.09-0.190.10.190.82-0.24-0.20.840.81-0.330.29-0.410.98-0.15-0.36-0.870.98-0.210.99
0.250.12-0.61-0.67-0.58-0.54-0.25-0.04-0.270.170.45-0.56-0.160.730.810.09-0.07-0.420.8-0.14-0.51-0.50.760.130.83
0.670.98-0.32-0.51-0.490.71-0.06-0.09-0.43-0.46-0.4-0.240.46-0.37-0.330.09-0.370.07-0.320.0-0.230.49-0.40.66-0.32
-0.31-0.240.150.550.67-0.31-0.15-0.320.810.210.270.65-0.240.10.29-0.07-0.370.030.180.610.52-0.290.27-0.380.21
-0.080.080.460.30.250.290.52-0.360.32-0.1-0.310.310.08-0.6-0.41-0.420.070.03-0.360.250.220.33-0.34-0.23-0.42
-0.19-0.32-0.35-0.42-0.3-0.90.07-0.220.040.20.81-0.32-0.210.80.980.8-0.320.18-0.36-0.24-0.39-0.870.99-0.220.99
0.110.150.050.450.560.19-0.40.020.60.31-0.330.55-0.32-0.13-0.15-0.140.00.610.25-0.240.420.31-0.180.01-0.19
0.09-0.160.670.610.790.18-0.120.020.660.05-0.390.72-0.05-0.32-0.36-0.51-0.230.520.22-0.390.420.35-0.31-0.12-0.38
0.440.530.280.230.120.89-0.180.35-0.18-0.04-0.990.150.06-0.64-0.87-0.50.49-0.290.33-0.870.310.35-0.880.49-0.85
-0.23-0.38-0.28-0.32-0.19-0.930.07-0.210.140.20.82-0.22-0.220.80.980.76-0.40.27-0.340.99-0.18-0.31-0.88-0.260.99
0.570.69-0.14-0.33-0.30.48-0.310.52-0.46-0.26-0.49-0.110.290.08-0.210.130.66-0.38-0.23-0.220.01-0.120.49-0.26-0.19
-0.17-0.3-0.39-0.42-0.3-0.88-0.05-0.20.060.210.8-0.32-0.220.820.990.83-0.320.21-0.420.99-0.19-0.38-0.850.99-0.19
Click cells to compare fundamentals

NeuroMetrix Account Relationship Matchups

NeuroMetrix fundamental ratios Accounts

201920202021202220232024 (projected)
Common Stock Shares Outstanding968.1K3.0M5.1M7.8M1.0M941.2K
Total Assets6.9M8.0M24.9M24.7M21.4M17.5M
Other Current Liab2.1M1.5M853.2K589.9K1.2M1.9M
Total Current Liabilities3.4M2.3M1.4M1.1M1.2M1.2M
Total Stockholder Equity2.5M5.2M23.2M23.4M20.1M14.4M
Property Plant And Equipment Net1.4M876.2K673.9K536.2K543.6K599.7K
Net Debt(2.2M)(4.8M)(22.3M)(3.9M)(1.5M)(1.6M)
Retained Earnings(194.8M)(196.9M)(199.2M)(203.6M)(210.1M)(220.6M)
Accounts Payable725.7K142.3K284.0K368.1K215.5K204.7K
Cash3.1M5.2M22.6M4.3M1.7M1.6M
Non Current Assets Total1.5M904.7K700.3K562.6K570.0K541.5K
Non Currrent Assets Other74.9K29.7K28.5K26.4K30.4K31.9K
Other Assets30.3K29.7K721.2K700.3K630.3K600.4K
Cash And Short Term Investments3.1M5.2M22.6M21.2M18.0M12.0M
Net Receivables488.0K334.3K310.8K646.8K518.8K492.9K
Common Stock Total Equity271.0738.0140.0379.0341.1669.34
Liabilities And Stockholders Equity6.9M8.0M24.9M24.7M21.4M17.5M
Non Current Liabilities Total916.7K461.4K306.7K207.5K92.5K87.9K
Inventory1.2M1.1M706.6K1.6M1.6M1.6M
Other Current Assets2.3M1.9M1.6M2.9M779.0K740.1K
Other Stockholder Equity197.3M202.1M222.4M226.9M230.0M241.5M
Total Liab4.4M2.7M1.7M1.3M1.3M1.3M
Property Plant And Equipment Gross1.4M183.5K2.0M1.2M1.3M926.1K
Total Current Assets5.4M7.1M24.2M24.1M20.9M15.7M
Accumulated Other Comprehensive Income(1.1M)(1.2M)(1.2M)240.2K216.2K227.0K
Common Stock140.0379.0668.0778.0152.0144.4
Property Plant Equipment2.4M273.4K183.5K673.9K606.5K621.0K
Retained Earnings Total Equity(191.3M)(191.0M)(194.8M)(196.9M)(177.2M)(186.1M)
Net Tangible Assets6.1M2.5M5.2M23.2M26.7M28.0M
Capital Surpluse196.4M197.1M197.3M202.1M232.4M201.3M
Net Invested Capital2.5M5.2M23.2M23.4M20.1M13.4M
Net Working Capital2.0M4.8M22.8M23.0M19.6M12.9M
Capital Stock141.0380.0669.0779.0153.0145.35
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards NeuroMetrix in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, NeuroMetrix's short interest history, or implied volatility extrapolated from NeuroMetrix options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether NeuroMetrix offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NeuroMetrix's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neurometrix Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Neurometrix Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuroMetrix. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Complementary Tools for NeuroMetrix Stock analysis

When running NeuroMetrix's price analysis, check to measure NeuroMetrix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuroMetrix is operating at the current time. Most of NeuroMetrix's value examination focuses on studying past and present price action to predict the probability of NeuroMetrix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuroMetrix's price. Additionally, you may evaluate how the addition of NeuroMetrix to your portfolios can decrease your overall portfolio volatility.
Commodity Directory
Find actively traded commodities issued by global exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Is NeuroMetrix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeuroMetrix. If investors know NeuroMetrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeuroMetrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(6.27)
Revenue Per Share
5.664
Quarterly Revenue Growth
(0.29)
Return On Assets
(0.19)
Return On Equity
(0.30)
The market value of NeuroMetrix is measured differently than its book value, which is the value of NeuroMetrix that is recorded on the company's balance sheet. Investors also form their own opinion of NeuroMetrix's value that differs from its market value or its book value, called intrinsic value, which is NeuroMetrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeuroMetrix's market value can be influenced by many factors that don't directly affect NeuroMetrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeuroMetrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if NeuroMetrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeuroMetrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.